Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY-NC-NDHematological oncology

Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis

  • Mariarita Sciumè1
  • Alessandro Bosi1
  • Alfredo Marchetti2
  • Fabio Serpenti1
  • Pasquale De Roberto1
  • Sonia Fabris1
  • Francesco Versino1
  • Elena Tagliaferri1
  • Francesco Passamonti1
  • Nicola Stefano Fracchiolla1
  1. 1Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
  2. 2Università Degli Studi di Milano
Read full textPDFCite

Related

  1. Combination therapy with nelarabine, pegaspargase, and venetoclax for adult patients with R/R T-cell ALL/LBL
    Niranjan Khaire, Elias Jabbour, Tapan Kadia +11
    Blood neoplasiaPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Long-term prophylaxis for hereditary angioedema: Navigating the switch between therapies☆
    Aleena Banerji, Jonathan A. Bernstein, Laurence Bouillet +11
    The World Allergy Organization journalPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Fungal Pathogenesis at the Host–Pathogen Interface: Immune Recognition, Evasion, Antifungal Resistance, and Emerging Therapies
    Tropical medicine and infectious diseasePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Enhanced Antileukemic Efficacy of Venetoclax-Loaded PEG-PLGA Nanoparticles Against THP-1 Acute Monocytic Leukemia Cells via Suppression of BCL-2 and Pro-Survival Signaling Pathways
    Nermin Keni Begendi, Elif Kaga
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Combining the Telomerase Inhibitor Imetelstat with the BCL-2 Inhibitor Venetoclax Enhances Apoptosis and Improves Survival in Acute Myeloid Leukemia Cellular and Animal Models
    Fei Huang, Joshua J. Rusbuldt, Leopoldo Luistro +2
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{sciume2026realworld,
  title = {{Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis}},
  author = {Mariarita Sciumè and Alessandro Bosi and Alfredo Marchetti and Fabio Serpenti and Pasquale De Roberto and Sonia Fabris and Francesco Versino and Elena Tagliaferri and Francesco Passamonti and Nicola Stefano Fracchiolla},
  journal = {Hematological oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13660767},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis
AU  - Mariarita Sciumè
AU  - Alessandro Bosi
AU  - Alfredo Marchetti
AU  - Fabio Serpenti
AU  - Pasquale De Roberto
AU  - Sonia Fabris
AU  - Francesco Versino
AU  - Elena Tagliaferri
AU  - Francesco Passamonti
AU  - Nicola Stefano Fracchiolla
PY  - 2026
DA  - 2026/10/13
JO  - Hematological oncology
UR  - https://europepmc.org/article/PMC/PMC13660767
SN  - 0278-0232
SN  - 1099-1069
ER  -